Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Crinetics Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 28, 2026
Crinetics Pharmaceuticals

Crinetics Pharmaceuticals

Public

San Diego-based Crinetics Pharmaceuticals develops therapeutics for endocrine diseases and cancers.

HQ
San Diego, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to developing therapeutics for endocrine diseases and cancers. The company's core mission is to provide effective disease control and simplify the lives of patients with these conditions. Crinetics collaborates with healthcare practitioners to address real medical needs and aims to create value for investors by filling significant market gaps.

Crinetics Pharmaceuticals has attracted notable investors and industry experts, contributing to its growing reputation in the biotech sector. The company has achieved key milestones in its clinical trials, advancing several promising drug candidates. Its overall impact lies in its commitment to addressing unmet medical needs, thereby improving patient outcomes and advancing the field of endocrine therapeutics.

Crinetics Pharmaceuticals - Similar Companies

Neurocrine B logo

Neurocrine B

neurocrine.com

Innocrin Pharmaceuticals logo

Innocrin Pharmaceuticals

innocrinpharma.com

CinRx Pharma logo

CinRx Pharma

cinrx.com

Xeris Biopharma Holdings logo

Xeris Biopharma Holdings

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Escient Pharmaceuticals logo

Escient Pharmaceuticals

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Sorrento Therapeutics logo

Sorrento Therapeutics

Chromis Therapeutics logo

Chromis Therapeutics

Kronos Bio logo

Kronos Bio

Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

kiniksa.com

Corcept Therapeutics logo

Corcept Therapeutics

corcept.com

Innovo Therapeutics logo

Innovo Therapeutics

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Crinetics Pharmaceuticals - Quick Facts

Who are Crinetics Pharmaceuticals' competitors?

Companies similar to Crinetics Pharmaceuticals include Neurocrine B, Innocrin Pharmaceuticals, CinRx Pharma and Xeris Biopharma Holdings.

When was Crinetics Pharmaceuticals founded?

Crinetics Pharmaceuticals was founded in 2008.

Where is Crinetics Pharmaceuticals' headquarters located?

Crinetics Pharmaceuticals' headquarters is located in San Diego, CA, US.

When was Crinetics Pharmaceuticals' last funding round?

Crinetics Pharmaceuticals' most recent funding round was for $350M (USD) in September 2023.

How much has Crinetics Pharmaceuticals raised to-date?

As of Sep 13, 2023, Crinetics Pharmaceuticals has raised a total of $796M (USD).

How many employees does Crinetics Pharmaceuticals have?

Crinetics Pharmaceuticals has 210 employees as of Feb 6, 2024.

Crinetics Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Financial
  • SaaS
Unique IDs
  • ein: 263744114
  • secCik: 0001658247
  • ticker: CRNX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research